Ultime notizie per Interparfums (NASDAQ:IPAR) Azioni

Interparfums

Inter Parfums

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

Interparfums Inc

Inter Parfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-06. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Inter Parfums will report an earnings per share (EPS) of $1.83.
Inter Parfums bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings History Snapshot</h3>
In the previous earnings release, the company beat EPS by $0.05, leading to a 1.86% increase in the share price the following trading session.
Here's a look at Inter Parfums's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.09</td>
<td>1.54</td>
<td>0.38</td>
<td>1.31</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.14</td>
<td>1.27</td>
<td>0.32</td>
<td>1.66</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>-4.0%</td>
<td>-5.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730822482_0_1.png" alt="eps graph" />
<h3>Tracking Inter Parfums's Stock Performance</h3>
Shares of Inter Parfums were trading at $123.91 as of November 04. Over the last 52-week period, shares are down 2.56%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/IPAR/earnings">To track all earnings releases for Inter Parfums visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

IPAR

Inter Parfums Earnings Preview

BWS Financial analyst Hamed Khorsand maintains Interparfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) with a Buy and maintains $172 price target.

News

Price Target

Analyst Ratings

BWS Financial Maintains Buy on Interparfums, Maintains $172 Price Target

Analysts' ratings for Interparfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Interparfums, presenting an average target of $170.6, a high estimate of $192.00, and a low estimate of $163.00. No alteration is observed as the current average remains at the previous average price target. 
<img src="https://www.benzinga.com/files/images/story/2024/1729598481_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A comprehensive examination of how financial experts perceive Interparfums is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Hamed Khorsand</td>
<td>BWS Financial</td>
<td>Maintains</td>
<td>Buy</td>
<td>$172.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$192.00</td>
<td>$192.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Interparfums. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Interparfums compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Interparfums's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Interparfums's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/IPAR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Interparfums analyst ratings.</a>
<h2>Discovering Interparfums: A Closer Look</h2>
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef &amp; Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.
<h3>Breaking Down Interparfums's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Positive Revenue Trend: Examining Interparfums's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 10.67% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Interparfums's net margin excels beyond industry benchmarks, reaching 10.76%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 5.17%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Interparfums's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.71%, the company showcases efficient use of assets and strong financial health.
Debt Management: Interparfums's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.26.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Interparfums Stock

DA Davidson analyst Linda Bolton Weiser maintains Interparfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) with a Buy and maintains $163 price target.

DA Davidson Maintains Buy on Interparfums, Maintains $163 Price Target

Achieves Best Quarterly Sales Performance in Company History; Reaffirms FY2024 Guidance 2024 Third Quarter Conference Call Scheduled for November 7, 2024
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) ("Interparfums" or the "Company") today announced that for the three months ended September 30, 2024, net sales rose to a record $425 million, up 15% from $368 million in the third quarter of 2023.
<figure class="table"> 
<table>
<tbody>
<tr>
<td rowspan="3">Net Sales ($ in millions) Data may not foot due to rounding</td>
<td colspan="9">Three Months Ended</td>
<td colspan="9">Nine Months Ended</td>
</tr>
<tr>
<td colspan="9">September 30,</td>
<td colspan="9">September 30,</td>
</tr>
<tr>
<td>2024</td>
<td>2023</td>
<td>% Change</td>
<td>2024</td>
<td>2023</td>
<td>% Change</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Total Interparfums, Inc.</td>
<td>$</td>
<td>425</td>
<td>$</td>
<td>368</td>
<td>15</td>
<td>%</td>
<td>$</td>
<td>1,091</td>
<td>$</td>
<td>989</td>
<td>10</td>
<td>%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>European based net sales</td>
<td>$</td>
<td>282</td>
<td>$</td>
<td>233</td>
<td>21</td>
<td>%</td>
<td>$</td>
<td>739</td>
<td>$</td>
<td>662</td>
<td>12</td>
<td>%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>United States based net sales</td>
<td>$</td>
<td>146</td>
<td>$</td>
<td>134</td>
<td>9</td>
<td>%</td>
<td>$</td>
<td>362</td>
<td>$</td>
<td>327</td>
<td>11</td>
<td>%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Eliminations of intercompany sales</td>
<td>$</td>
<td>(4</td>
<td>)</td>
<td>-</td>
<td>n/a</td>
<td>$</td>
<td>(11</td>
<td>)</td>
<td>-</td>
<td>n/a</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="19">- The average dollar/euro exchange rate for the 2024 third quarter was 1.10 compared to 1.09 in the 2023 third quarter, while for the first nine months of 2024, the average dollar/euro exchange rate was 1.09, compared to 1.08 in the first nine months of 2023, leading to a positive 0.4% and 0.2% foreign exchange impact for the third quarter and first nine months of 2024, respectively. - Eliminations of intercompany sales relate to European based operations product sales to United States based operations.</td>
</tr>
</tbody>
</table>
</figure>
Management Commentary: Jean Madar, Chairman &amp; Chief Executive Officer of Interparfums, stated, "Sales in the current third quarter were the highest for any quarter in our history. The ongoing strength of the global fragrance market, the solid performance of our largest brands, and the addition of our newest brands, Lacoste and Roberto Cavalli, which contributed 10% to our growth, led to our record top line performance.
"European based operations net sales increased 21% from the prior year period, primarily led by Jimmy Choo and Montblanc with 17% and 10% sales growth, respectively. Jimmy Choo brand sales accelerated during the quarter, driven by the launch of I Want Choo Le Parfum, while Montblanc brand sales were propelled by ongoing strength in the Explorer and Legend lines.
"With regard to Coach, our established lines achieved sales that approximated those of the 2023 third quarter when comparable brand sales rose 32%. Our sales growth also reflected the addition of Lacoste and its well-received debut of the Lacoste Original line."
Mr. Madar continued, "Many of our mid-sized brands also contributed to our quarterly sales growth. In the absence of a major launch, Lanvin sales rose 31% due to the resumption of normalized sales in Eastern Europe and Asia, partially offsetting the decline in sales observed in the first half of the year, and Karl Lagerfeld grew sales 19% with an expanded product offering that includes a new pillar, Ikonik."
Discussing United States based operations, Mr. Madar noted, "Building on the healthy 12% sales growth during the first half of 2024, third quarter sales rose 9%, compared to the prior year period. Of note, this result is all the more worth highlighting given the challenging comparison to the third quarter of 2023, where sales grew 64% from the prior year period.
"Sales from our largest United States brand, GUESS, grew 16% during the quarter, attributable to the continued performance of legacy scents, and the roll-out of GUESS Iconic, which is becoming a huge success.
"Sales from our second largest United States brand duo, Donna Karan/DKNY, now entering its third year under our expertise, grew 4% during the quarter. The new entrant for the brand, DKNY 24/7 is rolling out globally, following the successful yet limited distribution to select markets over the summer. Full distribution began in September, and we look for further sales momentum through the balance of the year, giving us confidence that it will become the next $100 million brand in our portfolio.
"Despite the 55% increase in Ferragamo sales in last year's third quarter, brand sales gained further traction in the current period aided by the success of the latest brand enrichment, Signorina Unica.
"For our new brand, Roberto Cavalli, Sweet Ferocious debuted in August, and we already began shipping the Wild Heart duo, which is scheduled to be in stores next month, in time for holiday season sales."
Mr. Madar concluded, "It's been a great year so far, and we are well positioned in this growing, dynamic, and competitive marketplace to support our retailers and distributors, as we build upon our past successes with innovative new products supported by well-planned and executed advertising and promotional programs. While the pace of growth is starting to slow down, the power of our diverse brand portfolio, in combination with our agile operating model, should help us gain market share."
Guidance The Company reaffirms its previously announced 2024 guidance of net sales of $1.45 billion, resulting in earnings per diluted share of $5.15. Initial full-year 2025 guidance is scheduled to be announced on Tuesday, November 12, 2024, after the market close.

Guidance

Interparfums, Inc. Reports Q3 Net Sales Of $425M Vs $368M YoY;  Reaffirms Its Previously Announced 2024 Guidance Of Net Sales Of $1.45B, Resulting In Earnings Per Diluted Share Of $5.15

Nu Skin Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nus#NYSE">NUS</a>) is driving its growth strategy through key initiatives that aim to revitalize its market presence and tap into high-growth areas. The company continues to prioritize thoughtful product introductions that align with shifting consumer preferences. A recent example is the launch of MYND360, a new line of clinically validated nutritional formulas tailored to support cognitive well-being.
Featuring six products, MYND360 is designed to enable users to manage stress, remain focused, enhance memory and sleep better. This innovation reflects Nu Skin&#39;s focus on the fast-growing brain health market. While these upsides, along with strength in the Rhyz business, have been working well. Nu Skin remains troubled by persistent macroeconomic obstacles.
<h2>Product Launches a Key Driver for Nu Skin</h2>
With the help of advanced technology and well-strategized product programs, Nu Skin tries to capture greater market share and maintain growth momentum. The company&#39;s long-term strategies stand on three key pillars &mdash; Products, Programs and Platforms. NUS has been successfully launching innovative beauty devices, which have become an important part of its growth.
Nu Skin&#39;s second-quarter 2024 results included positive contributions from new products such as Ageloc, Wellspa IO and RenewspA IO, along with the company&#39;s TRME weight management system. The ageLOC WellSpa iO has been a solid addition to the company&#39;s beauty device system brands, generating impressive response.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/78/81418.jpg?v=533402966" />
Image Source: Zacks Investment Research
<h2>Nu Skin Gains From Rhyz Business</h2>
Nu Skin&#39;s Rhyz business emerges as a cornerstone of its strategic vision, highlighted by its remarkable growth trajectory and significant contribution to the company&#39;s revenue stream. Rhyz represents a cohesive ecosystem comprising consumer, technology, and manufacturing entities, all dedicated to pioneering innovation within the realms of beauty, wellness, and lifestyle. Experiencing 32.3% revenue growth in the second quarter of 2024, Rhyz accounted for 15% of total enterprise revenues and is anticipated to reach 20% to 25% by 2025.
The success of this business reflects Nu Skin&#39;s commitment to capitalizing on evolving consumer trends, particularly in influencer and affiliate marketing, which are projected to surge in the coming years. By investing in Rhyz&#39;s manufacturing capabilities, technology advancements, and creator-led indie beauty brands, Nu Skin is strategically positioning itself to drive sustained growth and value creation within the beauty, wellness, and lifestyle market.
<h2>Challenges Faced by NUS</h2>
Nu Skin&#39;s second-quarter 2024 performance was hurt by continuous macroeconomic headwinds across most regions, which weighed on consumer spending and customer acquisition, especially for premium products. The company also grappled with pressures in the direct selling industry. These headwinds, along with foreign adverse currency fluctuations, hurt Nu Skin&#39;s quarterly revenues, which tumbled 12.2% year over year to $439.1 million in the second quarter.
The operating environment for Nu Skin&#39;s core business remains challenging, primarily due to macroeconomic factors and pressures within the direct selling industry. Taking into account the company&#39;s first-half 2024 performance and rising foreign exchange headwinds, management tightened the annual guidance range for 2024 in its second-quarter earnings release.
Nu Skin now anticipates revenues in the band of $1.73-$1.81 billion for 2024, which suggests a 12-8% decline from the year-ago period&#39;s reported figure. Earlier, the metric was expected to be in the range of $1.73-$1.87 billion. Management envisions adjusted earnings per share of 75-95 cents. The projection suggests a decline from adjusted earnings of $1.85 recorded in 2023. Management had earlier envisioned an adjusted EPS of 95 cents to $1.35 for 2024.
For the third quarter of 2024, the company expects revenues between $430 million and $465 million, which suggests a decline of 14% to 7% from the year-ago quarter&#39;s reported level. The company expects adjusted EPS of 15-25 cents in the third quarter of 2024 compared with 56 cents recorded in the same period last year. Shares of NUS have plunged 42.6% in the past three months compared with the industry&#39;s decline of 10%.
<h2>Final Words on NUS</h2>
Nu Skin continues to drive growth through strategic initiatives, innovative product launches, and the expanding Rhyz business. While the company has made significant strides in capturing market opportunities, especially in the beauty and brain health sectors, it faces ongoing challenges from macroeconomic pressures and headwinds in the direct selling industry. Moving forward, the Zacks Rank #3 (Hold) company&#39;s ability to balance innovation with market realities will be key to sustaining its growth trajectory.
<h2>Top 3 Staple Bets</h2>
Inter Parfums (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipar#NASDAQ">IPAR</a>) is engaged in the manufacturing, distribution and marketing of a wide range of fragrances and related products. It currently carries a Zacks Rank of 2 (Buy).
The Zacks Consensus Estimate for IPAR&#39;s current financial-year sales and earnings indicates advancements of 10.2% and 8.4%, respectively, from the prior-year figures. It has a trailing four-quarter earnings surprise of 2.5%, on average.
Flowers Foods (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/flo#NYSE">FLO</a>), one of the largest producers of packaged bakery foods in the United States, currently carries a Zacks Rank #2. FLO has a trailing four-quarter earnings surprise of 1.9%, on average.
The Zacks Consensus Estimate for Flowers Foods&#39; current financial-year sales and earnings implies growth of around 1% and 5%, respectively, from the year-ago reported numbers.
McCormick &amp; Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mkc#NYSE">MKC</a>) is a leading manufacturer, marketer and distributor of spices, seasonings, specialty foods and flavors. It currently carries a Zacks Rank #2.
The Zacks Consensus Estimate for McCormick &amp; Company&#39;s current fiscal-year sales and earnings indicates advancements of 0.6% and 8.2%, respectively, from the year-ago reported figures. MKC has a trailing four-quarter earnings surprise of 13.8%, on average.
<a href="https://www.zacks.com/stock/news/2351561/nu-skin-navigates-growth-with-innovation-amid-industry-challenges?cid=CS-BENZ-FT-analyst_blog|rank_focused-2351561">To read this article on Zacks.com click here.</a>

Large Cap

Macro Economic Events

Mid Cap

Small Cap

Management

Economics

Markets

Trading Ideas

Nu Skin Navigates Growth With Innovation Amid Industry Challenges

DA Davidson analyst Linda Bolton Weiser maintains Inter Parfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) with a Buy and maintains $163 price target.

DA Davidson Maintains Buy on Inter Parfums, Maintains $163 Price Target

In the preceding three months, 7 analysts have released ratings for Inter Parfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>), presenting a wide array of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $165.71, a high estimate of $192.00, and a low estimate of $140.00. A decline of 2.52% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1726254020_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The perception of Inter Parfums by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Hamed Khorsand</td>
<td>BWS Financial</td>
<td>Maintains</td>
<td>Buy</td>
<td>$172.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$192.00</td>
<td>$192.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$151.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$192.00</td>
<td>$192.00</td>
</tr>
<tr>
<td>Ashley Helgans</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Buy</td>
<td>$140.00</td>
<td>-</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$151.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Inter Parfums. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Inter Parfums compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Inter Parfums's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Inter Parfums's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/IPAR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Inter Parfums analyst ratings.</a>
<h2>All You Need to Know About Inter Parfums</h2>
Inter Parfums Inc operates in the fragrance business and manufactures, markets, and distributes fragrances and fragrance-related products. It sells its product under the brand names called JIMMY CHOO, bebe, Paul Smith, Abercrombie and Fitch, COACH, and others. The company operates in two operating segments namely European based operations, and United-States operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.
<h3>Inter Parfums: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Inter Parfums's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 10.67%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Inter Parfums's net margin excels beyond industry benchmarks, reaching 10.76%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Inter Parfums's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.17% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Inter Parfums's ROA excels beyond industry benchmarks, reaching 2.71%. This signifies efficient management of assets and strong financial health.
Debt Management: Inter Parfums's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.26.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Inter Parfums Through The Eyes Of 7 Analysts

The Estee Lauder Companies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/el#NYSE">EL</a>) exhibited a volatile stock trajectory in recent months, driven by weak consumer sentiment amid high inflation and rising interest rates. The company is also grappling with issues such as market instability in mainland China and Asia travel retail, lower conversion rates, and negative foreign currency impacts.
As a result, shares of this New York-based provider of skincare, makeup, fragrance and hair care products have plunged 42.4% year to date compared with a 37.7% drop in the broader industry. In contrast, the Consumer Staple sector and the S&amp;P 500 have posted increases of 9.4% and 16.3%, respectively, during the same period. Closing the trading session at $84.20 on Thursday, shares of EL stand close to its recently reached 52-week low of $82.39.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/a0/77666.jpg?v=1703756740" style="height:310px; width:600px" />
Image Source: Zacks Investment Research
EL is trading below its 50 and 200-day moving averages, indicating a bearish outlook and challenges in sustaining the recent performance levels.
<h2>EL Stock Trades Below 50 and 200-Day Moving Average</h2>
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/a1/77668.jpg?v=68533591" style="height:310px; width:600px" />
Image Source: Zacks Investment Research
<h2>Decoding Challenges Faced by EL</h2>
In the fiscal 2024, The Estee Lauder Companies faced significant challenges in the Asia-Pacific region, particularly in mainland China, due to a broader slowdown in the prestige beauty sector. Sales in the Asia-Pacific region fell 7% to $1,205 million during the fiscal fourth quarter. The downtick was largely caused by weakness in mainland China. Consumer confidence remained low and cautious spending behavior contributed to a decline in prestige beauty retail sales, which worsened from mid-single digits in the third quarter to low-double digits. The Asia travel retail market also struggled, with sales in Hainan plunging more than 40% in the fiscal fourth quarter. Weaker consumer sentiment, smaller basket sizes and a shift toward spending on experiences played a key role in these declines. Looking ahead to fiscal year 2025, the recovery in China and Asia travel retail is expected to be slow, which might limit sales growth and profitability in these key markets.
Another concerning point is the contraction in adjusted operating margins, which contracted 120 basis points to 10.2% in the fiscal 2024. While there was a modest recovery in the later part of the fiscal 2024, the outlook for fiscal 2025 indicates a slower-than-expected pace of margin expansion. This delay is partially attributed to continued pressure from high-margin categories like skin care, which are still facing declines in sales.
The company is losing market share in channels that are growing more slowly, such as traditional retail, despite some gains in high-growth platforms like Amazon. However, these gains are not enough to offset losses in brick-and-mortar stores, particularly in North America, where competition is fierce.
The Estee Lauder Companies faces significant financial pressure due to unfavorable currency rates. Currency fluctuations, particularly in regions like Israel and the Middle East, compounded by business disruptions, further impacted the company&#39;s profitability in the fiscal 2024. These currency headwinds are expected to continue affecting earnings, potentially reducing earnings per share by approximately 3 cents in the fiscal 2025.
<h2>What to Expect From The Estee Lauder Companies in FY25?</h2>
The company continues to face a challenging macroeconomic environment, with ongoing volatility in the global prestige beauty market, especially in mainland China and Asia travel retail. For fiscal year 2025, management expects a more modest performance compared to industry averages, primarily due to its strong presence in these regions. Weak consumer sentiment and changing traveler behavior, with more spending on experiences over products, are impacting Asia travel retail. Additionally, risks such as retailer destocking and intense competition, particularly in North America, are further complicating the company&#39;s outlook.
In the first quarter of fiscal 2025, the company anticipates continued pressure from these challenges, projecting a 3-5% year-over-year decline in reported and organic net sales. Adjusted EPS are expected to fall sharply, ranging between 1 and 9 cents and suggesting a decline of 17-89% on a constant-currency basis.
<h2>Analysts Downgrade EL&#39;s Earnings Estimates</h2>
EL appears to be in a troubled spot. The Zacks Consensus Estimate for the current and next fiscal year EPS has moved downward by 2.9% and 4.3% to $2.97 and $4.03, respectively, in the past seven days. This downward adjustment reflects a negative sentiment among analysts and suggests potential challenges in achieving projected profitability.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/2f/77665.jpg?v=137859411" style="height:310px; width:600px" />
Image Source: Zacks Investment Research
<h2>EL&#39;s Valuation Premium Raises Questions</h2>
The Estee Lauder Companies valuation remains a point of contention. Despite the pullback in the stock price, EL is trading at a premium relative to industry peers like Coty Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/coty#NYSE">COTY</a>) and Inter Parfums, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipar#NASDAQ">IPAR</a>), which seems increasingly difficult to justify. EL is currently trading at a forward 12-month P/E of 25.99, higher than the industry&#39;s 21.89. This valuation discrepancy indicates that while investors have high expectations for the company&#39;s future growth, the stock&#39;s current performance and the broader market challenges could pose risks.
<h2>Can Growth Strategies Turn the Tide?</h2>
Despite several challenges, The Estee Lauder Companies is making significant strides with its Profit Recovery and Growth Plan (PRGP). This initiative focuses on three core areas &mdash; accelerating margin expansion, targeted growth investments, and simplifying processes for greater agility. For the fiscal 2025, the PRGP is expected to deliver substantial benefits, with around 80% of gains improving gross profit through optimized pricing, reduced discounts and enhanced precision marketing. The remaining 20% aims to cut operating expenses by streamlining operations and expanding shared services. These efforts are projected to generate $1.1-$1.4 billion in net savings by the fiscal 2026.
The company is also leveraging its strengths in high-growth areas, including its global prestige skin care portfolio and luxury fragrance brands such as Jo Malone London, TOM FORD and Le Labo. Its focus on digital transformation is another key growth driver, with strong online sales growth across nearly 50 markets. Digital initiatives, combined with precision marketing using AI and consumer profiles, position the company for sustained growth and future market leadership.
While EL is resorting to restructuring, the fiscal 2025 forecast reveals more conservative sales growth and profitability improvements than originally anticipated. This suggests that the company&#39;s recovery will take longer than planned, leaving investors wary of future profitability in the near term.
<h2>What&#39;s Next for Investors?</h2>
The Estee Lauder Companies is facing significant challenges, including weak consumer sentiment, declining sales in key markets like China, and currency headwinds. Its reliance on Asia travel retail and luxury beauty has led to pressure on margins and overall profitability. The stock is trading below key moving averages, signaling a bearish trend. While the profit recovery plan aims to improve margins and streamline operations, the road to recovery might be longer than anticipated. With a lofty valuation and analysts downgrading earnings estimates, investors should approach EL stock with caution. EL currently carries a Zacks Rank #5 (Strong Sell).
<a href="https://www.zacks.com/stock/news/2335963/el-trading-near-52-week-low-how-should-investors-approach-the-stock?cid=CS-BENZ-FT-analyst_blog|most_popular_stocks-2335963">To read this article on Zacks.com click here.</a>

Asia

Retail Sales

COTY

EL Trading Near 52-Week Low: How Should Investors Approach the Stock?

In the Zacks Cosmetics industry, companies are facing challenges from inflationary pressures, which have been compounded by a general decline in discretionary spending stemming from higher cost of living and elevated interest rates. These factors have impacted consumer demand across the sector.
Nevertheless, initiatives aimed at enhancing digital capabilities and fostering innovation have proven beneficial for firms such as Coty Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/coty#NYSE">COTY</a>), Inter Parfums, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipar#NASDAQ">IPAR</a>), Waldencast plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wald#NASDAQ">WALD</a>) and Olaplex Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olpx#NASDAQ">OLPX</a>).
About the Industry
The Zacks Cosmetics industry includes companies that provide beauty and personal care products. Players in the industry manufacture, distribute, sell and market skincare, fragrance, makeup and hair care products. Many firms in the space market sell products via sales representatives, whereas some do the same through retailers, independent and chain drug stores and pharmacies, upscale perfumeries, department stores and beauty salons. These companies also operate through retailer websites, third-party distributors and in-flight and duty-free shops. Some products offered by industry participants include moisturizers, serums, toners and cleansers under skincare; perfume sprays, candles and soaps under fragrance; lipsticks, mascaras, powders, eye shadows, foundation and nail polishes under makeup; and shampoos, conditioner and hair color products under hair care.
Trends Shaping the Future of the Cosmetics Industry
Inflationary Headwinds: Cosmetic companies are grappling with inflationary pressures, which are escalating expenses across various areas such as raw materials, energy, labor and packaging, among others. Many firms are vulnerable to shipping disruptions, which can result in delays and higher freight expenses, squeezing overall profit margins. The elevated cost of living and interest rates are prompting consumers to reduce discretionary spending, affecting the demand for cosmetic products.
International Risk Factors: Several industry players face potential risks due to their global footprint, including exposure to adverse foreign currency fluctuations. Political unrest, like turmoil related to geopolitical events, might disrupt market access and operational continuity. Trade conflicts, tariffs, sanctions and other restrictions may also affect their performance.
Innovation &amp; Digitization &ndash; Major Drivers: Innovation and digitization are pivotal to the beauty and skincare industry. Consumers increasingly seek unique products that combine advanced technologies with expert scientific formulations. To address ever-evolving preferences, cosmetic companies are continuously innovating and introducing new products. Growing awareness of organic and &#39;clean beauty&#39; products has further fueled demand. Enhancing e-commerce capabilities is a top focus, leading to advancements like virtual try-on tools, digital payment solutions and improved digital marketing strategies. Additionally, companies are expanding their brand portfolios through strategic acquisitions and partnerships.
Strong Demand for Skincare &amp; Makeup: The robust demand for skincare and makeup is a boon for numerous cosmetics companies. Consumers&#39; heightened emphasis on self-care and adhering to healthy skincare regimens propelled the skincare segment. Similarly, the makeup category remains popular, contributing to the overall expansion of cosmetics companies. Players in this sector are registering strength in fragrance and haircare products, driven by innovations and new product launches. These positive trends are likely to keep supporting the top-line performance of cosmetics companies moving forward.
Zacks Industry Rank Indicates Dull Prospects
The Zacks Cosmetics industry is housed within the broader Zacks Consumer Staples sector. The industry currently carries a Zacks Industry Rank #211, which places it in the bottom 16% of more than 250 Zacks industries.
The group&#39;s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates solid near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
The industry&#39;s position in the top 50% of the Zacks-ranked industries leads to a negative aggregate earnings outlook for the constituent companies. Looking at the aggregate earnings estimate revisions, it appears that analysts are gradually losing confidence in this group&#39;s earnings growth potential. Since the beginning of Jun 2024, the industry&#39;s consensus estimate for current financial year earnings has decreased 4%.
Before we present a few stocks that you may want to consider for your portfolio, let&#39;s look at the industry&#39;s recent stock-market performance and valuation picture.
Industry Vs. Broader Market
The Zacks Cosmetics industry has underperformed the Zacks S&amp;P 500 composite and the broader Zacks Consumer Staples sector over the past year.
The industry has moved down 40.5% over this period, against the S&amp;P 500&#39;s growth of 19.1%. The broader sector has dropped 1.4% in the said time frame.
<h3>One-Year Price Performance</h3>
<h3><img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/io_price.jpg" style="height:127px; width:620px" /></h3>
Industry&#39;s Current Valuation
On the basis of forward 12-month Price-to-earnings (P/E), which is commonly used for valuing consumer staples stocks, the industry is currently trading at 20.49X compared with the S&amp;P 500&#39;s 20.71X and the sector&#39;s 17.55X.
In the past five years, the industry has traded as high as 43.55X, as low as 20.49X, and at the median of 31.71X, as the chart below shows.
<h3>Price-to-Earnings Ratio (Past 5 Years)</h3>
<h3><img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/pe_io(3).jpg" style="height:99px; width:620px" /></h3>
4 Cosmetic Stocks Worth Watching
Coty: The manufacturer, marketer and distributor of beauty products carries a Zacks Rank #3 (Hold). Coty continues to benefit from robust growth in the global beauty market, driven by a strong brand presence and consumer demand. With a focus on six growth pillars, including growing Consumer Beauty and fragrances, COTY demonstrates a proactive approach to sustainable growth. By investing in core categories like skincare and expanding its e-commerce capabilities, the company aligns with evolving consumer preferences. Management&#39;s commitment to innovation and strategic partnerships enhances its competitive position across the beauty market. These fundamental factors underscore Coty&#39;s resilience and potential for long-term success, irrespective of short-term headwinds.
The Zacks Consensus Estimate for COTY&#39;s current fiscal year earnings per share has remained unchanged in the past 30 days at 44 cents. Coty&#39;s shares have dropped 21.3% in the past six months.
<h3>Price and Consensus: COTY</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/coty_io(1).jpg" style="height:275px; width:620px" />
Inter Parfums: The Zacks Rank #3 company manufactures, distributes and markets a wide range of fragrances and related products. Inter Parfums has been capitalizing on the strong momentum in the fragrance market, supporting the booming fragrance market and strength in its legacy and new brands. IPAR has been witnessing increased market share propelled by new product launches and brand extensions. Inter Parfums has been on track to expand its business through new licenses or acquisitions.
The Zacks Consensus Estimate for IPAR&#39;s current fiscal year earnings has remained unchanged at $5.15 in the past 30 days. Shares of Inter Parfums have dropped 13.1% in the past six months.
<h3>Price and Consensus: IPAR</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/ipar_2024(4).jpg" style="height:279px; width:620px" />
Olaplex: This innovative, science-enabled and technology-driven beauty company carries a Zacks Rank #3. The company is positioned for continued growth and success, driven by its strong brand equity, innovative product offerings and strategic investments. Olaplex&#39;s commitment to enhancing its marketing strategies and engaging deeply with the professional stylist community yielded positive early results, evidenced by increased social media engagement and brand visibility. The forthcoming product innovations underscore the company&#39;s leadership in hair care innovation.
The Zacks Consensus Estimate for OLPX&#39;s current fiscal year earnings has remained unchanged at 14 cents in the past 30 days. Shares of Olaplex have dropped 13.1% in the past six months.
<h3>Price and Consensus: OLPX</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/oplx_2024.jpg" style="height:273px; width:620px" />
Waldencast: This global multi-brand beauty and wellness platform, currently carries a Zacks Rank of 3. The company&#39;s agile and expert-driven platform, combined with a clear focus on innovation and community engagement, positions Waldencast to capitalize on emerging trends, enhance profitability and drive long-term value creation. WALD benefits from a robust online presence. Additionally, its focus on clean, high-performance beauty products aligns with the increasing consumer demand for sustainability. The company&#39;s strategic acquisitions and investments in cutting-edge innovation further enhance its market positioning, offering ample opportunities for global expansion.
The Zacks Consensus Estimate for WALD&#39;s current fiscal year bottom line has remained unchanged at a loss of 9 cents in the past 30 days. Shares of Waldencast have dropped 62.9% in the past six months.
<h3>Price and Consensus: WALD</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/wald_2024.jpg" style="height:278px; width:620px" />
<a href="https://www.zacks.com/commentary/2321769/4-cosmetics-stocks-worth-watching-amid-industry-challenges?cid=CS-BENZ-FT-industry_outlook-2321769">To read this article on Zacks.com click here.</a>

Penny Stocks

OLPX

WALD

4 Cosmetics Stocks Worth Watching Amid Industry Challenges

BWS Financial analyst Hamed Khorsand maintains Inter Parfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) with a Buy and maintains $172 price target.

BWS Financial Maintains Buy on Inter Parfums, Maintains $172 Price Target

Inter Parfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) reported quarterly sales of $342.00 million which beat the analyst consensus estimate of $337.71 million by 1.27 percent. This is a 10.59 percent increase over sales of $309.24 million the same period last year.

Earnings Beats

Inter Parfums Q2 Sales $342.00M Beat $337.71M Estimate

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Tuesday.
Shares of Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) rose sharply during Tuesday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/39907956/life-science-giant-danahers-q2-earnings-beat-estimates-on-sustained-positive-momentum-in-bioprocess">second quarter earnings</a>.
Danaher's second quarter sales decreased 3% year-over-year to $5.743 billion, beating the consensus of $5.59 billion. Danaher reported second-quarter adjusted EPS of $1.72, beating the consensus of $1.57, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
Danaher shares gained 7.4% to $269.35 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Kiniksa Pharmaceuticals International, plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) shares jumped 16% to $24.81 after the company reported better-than-expected second-quarter sales results and raised its FY24 net product revenue guidance.</li>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) gained 12.7% to $333.02 following second-quarter earnings.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) surged 11.8% to $12.34.</li>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) gained 11.8% to $6.90.</li>
<li>KKR Real Estate Finance Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KREF#NYSE">KREF</a>) surged 11.2% to $11.22 following second-quarter results.</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) shares jumped 11.1% to $561.96 following better-than-expected second-quarter financial results.</li>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) gained 10.3% to $66.27.</li>
<li>Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) gained 9% to $29.48. HC Wainwright &amp; Co. analyst Patrick Trucchio initiated coverage on Beam Therapeutics with a Buy rating and announced a price target of $80.</li>
<li>Iridium Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>) rose 8.5% to $28.11 after the company reported better-than-expected second-quarter EPS results.</li>
<li>Crown Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) gained 8.5% to $84.04 after the company reported better-than-expected second-quarter earnings and raised its FY24 EPS guidance above estimates.</li>
<li>MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) climbed 8% to $96.75 following better-than-expected quarterly earnings.</li>
<li>Inter Parfums, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) gained 8% to $137.34 after the company reported better-than-expected expected sales.</li>
<li>Owens &amp; Minor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) rose 8% to $16.51 as the company released preliminary second quarter 2024 financial results and signed a definitive agreement to acquire Rotech Healthcare for $1.36 billion in cash.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) shares gained 8% to $8.15. Mesoblast recently started enrollment in Phase 3 trial of Rexlemestrocel-L for chronic low back pain.</li>
<li>Pentair plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) gained 7.7% to $86.19 after the company reported better-than-expected second quarter financial results and revised its FY24 adjusted EPS guidance above estimates.</li>
<li>Park National Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRK#NYSE">PRK</a>) gained 7.4% to $182.78 following upbeat quarterly earnings.</li>
<li>Wheels Up Experience Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) gained 7.1% to $3.46.</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) shares surged 6.4% to $173.21 after the company reported better-than-expected second quarter adjusted EPS and raised its FY24 outlook.</li>
<li>SAP SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) gained 6% to $0.2390 after the company reported second-quarter financial results.</li>
<li>Hims &amp; Hers Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NASDAQ">HIMS</a>) gained 5.6% to $21.51.</li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) surged 5.5% to $178.95.</li>
<li>Zions Bancorporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) rose 5.4% to $52.12 after posting better-than-expected quarterly results on Monday.</li>
<li>Brown &amp; Brown, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) gained 5.2% to $97.99 following upbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39907046/best-buy-kroger-and-2-other-stocks-insiders-are-selling">Best Buy, Kroger And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

Intraday Update

Movers

BEAM

Hims & Hers Health, Inc. Class A Common Stock

HIMS

IRDM

KNSA

KREF

MESO

MMYT

MSCI

SPOT

ZION

Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday

Piper Sandler analyst Korinne Wolfmeyer reiterates Inter Parfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) with a Overweight and raises the price target from $150 to $151.

Reiteration

Piper Sandler Reiterates Overweight on Inter Parfums, Raises Price Target to $151

WIIM

Inter Parfums shares are trading higher after the company reported better-than-expected Q2 sales.

Inter Parfums Maintains Its Conservative Outlook; Reaffirms 2024 Guidance Of Net Sales Of $1.45B (Est $1.454B), Resulting In EPS Of $5.15 (Est $5.15)

Inter Parfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) reported quarterly sales of $342.000 million which beat the analyst consensus estimate of $337.711 million by 1.27 percent. This is a 10.59 percent increase over sales of $309.244 million the same period last year.

Inter Parfums Q2 Sales $342.000M Beat $337.711M Estimate

DA Davidson analyst Linda Bolton Weiser maintains Inter Parfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) with a Buy and maintains $192 price target.

DA Davidson Maintains Buy on Inter Parfums, Maintains $192 Price Target

Inter Parfums shares are trading higher after Jefferies upgraded the stock from Hold to Buy.

Inter Parfums: Fragrance Sales Surge To New Heights

In a report released today, Linda Bolton Weiser from D.A. Davidson reiterated a Buy rating on Inter Parfums (IPAR – Research Report). The company's...

D.A. Davidson Sticks to Its Buy Rating for Inter Parfums (IPAR)

Beauty category sags as Coty warns of slower U.S. sales

Interparfums' name change is approved by shareholders

Jean Madar, chairman and CEO of Interparfums, stated, "Sales in the current third quarter were the highest for any quarter in our history. The ongo...

Inter Parfums reports Q3 revenue $425M, consensus $413.45M

Backs FY24 revenue view $1.45B, consensus $1.45B. The company said, "The Company reaffirms its previously announced 2024 guidance of net sales of $...

Inter Parfums backs FY24 EPS view $5.15, consensus $5.16

Interparfums hits record Q3 sales

An update from Inter Parfums ( ($IPAR) ) is now available. Interparfums, Inc. achieved record net sales of $425 million in the third quarter of 202...

Inter Parfums Reports Record Q3 2024 Sales Growth

BWS Financial analyst Hamed Khorsand maintained a Buy rating on Inter Parfums (IPAR – Research Report) today and set a price target of $172.00. Ham...

Strong Brand Performance and Sales Growth Drive Buy Recommendation for Inter Parfums

Berenberg analyst Fraser Donlon lowered the firm's price target on Inter Parfums (IPAR) to EUR 54 from EUR 56 and keeps a Buy rating on the shares....

Inter Parfums price target lowered to EUR 54 from EUR 56 at Berenberg

Press Releases

Inter Parfums, Inc. Announces Initial 2024 Guidance

Inter Parfums, Inc. Reports Record 2023 Fourth Quarter and Full Year Net Sales

Inter Parfums, Inc. Schedules 2023 Fourth Quarter and Full Year Results

Inter Parfums, Inc. Reports 2023 Fourth Quarter and Record Full Year Results

Inter Parfums, Inc. Schedules 2024 First Quarter Results

Inter Parfums, Inc. Reports Record 2024 First Quarter Net Sales

Inter Parfums, Inc. Reports 2024 First Quarter Results

Inter Parfums, Inc. Reports Record 2024 Second Quarter Net Sales

Dividends

Inter Parfums, Inc. Reports Record 2024 Second Quarter Results

Interparfums, Inc. Reports Record 2024 Third Quarter Net Sales

BellRing Brands

Coty

Big Tree Cloud Holdings Limited - Ordinary Shares

Big Tree Cloud Holdings

Estee Lauder Companies, Inc. (The) Common Stock

Estee Lauder Cos

e.l.f. Beauty

Edgewell Personal Care Company Common Stock

Edgewell Personal Care

FitLife Brands

Herbalife

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Honest Co

Kenvue

Lifevantage

Medifast

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products

Natural Health Trends Corp. - Commn Stock

Natural Health Trends

Nu Skin Enterprises

Olaplex Hldgs

Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares

Paranovus Enter

Safety Shot

The Beauty Health Company - Class A Common Stock

Beauty Health

Unilever

Usana Health Sciences

Veru

Waldencast

Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares

Comments

Interparfums

Notizie

Ultime notizie per Interparfums (NASDAQ:IPAR) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO